☰

Tracy C. Kuo, Ph.D. - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
gene regulation in the immune system
Tree Info Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Panowski SH, Kuo TC, Zhang Y, Chen A, Geng T, Aschenbrenner L, Kamperschroer C, Pascua E, Chen W, Delaria K, Farias S, Bateman M, Dushin RG, Chin SM, Van Blarcom TJ, et al. Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma. Molecular Cancer Therapeutics. PMID 31434693 DOI: 10.1158/1535-7163.Mct-19-0007  0.365
2019 Sommer C, Boldajipour B, Kuo TC, Bentley T, Sutton J, Chen A, Geng T, Dong H, Galetto R, Valton J, Pertel T, Juillerat A, Gariboldi A, Pascua E, Brown C, et al. Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31005597 DOI: 10.1016/J.Ymthe.2019.04.001  0.461
2019 Kuo TC, Chen A, Harrabi O, Kauder SE, Sangalang ER, Doyle L, Bollini S, Han B, Sim J, Pons J, Wan HI. Abstract 562: Antibodies to Sirpα enhance innate and adaptive immune responses to promote anti-tumor activity Cancer Research. 79: 562-562. DOI: 10.1158/1538-7445.Am2019-562  0.327
2018 Kauder SE, Kuo TC, Harrabi O, Chen A, Sangalang E, Doyle L, Rocha SS, Bollini S, Han B, Sim J, Pons J, Wan HI. ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile. Plos One. 13: e0201832. PMID 30133535 DOI: 10.1371/Journal.Pone.0201832  0.375
2017 Kauder SE, Kuo TC, Chen A, Harrabi O, Rocha SS, Doyle L, Bollini S, Han B, Sangalang ERB, Sim J, Randolph S, Pons J, Wan HI. ALX148 Is a High Affinity Sirpα Fusion Protein That Blocks CD47, Enhances the Activity of Anti-Cancer Antibodies and Checkpoint Inhibitors, and Has a Favorable Safety Profile in Preclinical Models Blood. 130: 112-112. DOI: 10.1182/Blood.V130.Suppl_1.112.112  0.362
2016 Panowski SH, Kuo T, Chen A, Geng T, Van Blarcom TJ, Lindquist K, Chen W, Chaparro-Riggers J, Sasu B. Preclinical Evaluation of a Potent Anti-Bcma CD3 Bispecific Molecule for the Treatment of Multiple Myeloma Blood. 128: 383-383. DOI: 10.1182/Blood.V128.22.383.383  0.432
2016 Boldajipour B, Galetto R, Sommer C, Pertel T, Valton J, Park Y, Gariboldi A, Chen A, Geng T, Dong HH, Boucher GR, Van Blarcom TJ, Chaparro-Riggers J, Rajpal A, Smith J, ... Kuo T, et al. Preclinical Evaluation of Allogeneic Anti-Bcma Chimeric Antigen Receptor T Cells with Safety Switch Domains and Lymphodepletion Resistance for the Treatment of Multiple Myeloma Blood. 128: 381-381. DOI: 10.1182/Blood.V128.22.381.381  0.466
2014 Palanichamy A, Apeltsin L, Kuo TC, Sirota M, Wang S, Pitts SJ, Sundar PD, Telman D, Zhao LZ, Derstine M, Abounasr A, Hauser SL, von Büdingen HC. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Science Translational Medicine. 6: 248ra106. PMID 25100740 DOI: 10.1126/Scitranslmed.3008930  0.502
2013 Benichou J, Glanville J, Prak ET, Azran R, Kuo TC, Pons J, Desmarais C, Tsaban L, Louzoun Y. The restricted DH gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content. Journal of Immunology (Baltimore, Md. : 1950). 190: 5567-77. PMID 23630353 DOI: 10.4049/Jimmunol.1201929  0.324
2012 von Büdingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, Cree BA, Gourraud PA, Schwartzburg A, Huerta G, Telman D, Sundar PD, Casey T, Cox DR, Hauser SL. B cell exchange across the blood-brain barrier in multiple sclerosis. The Journal of Clinical Investigation. 122: 4533-43. PMID 23160197 DOI: 10.1172/Jci63842  0.458
2011 Kuo TC, Chavarria-Smith JE, Huang D, Schlissel MS. Forced expression of cyclin-dependent kinase 6 confers resistance of pro-B acute lymphocytic leukemia to Gleevec treatment. Molecular and Cellular Biology. 31: 2566-76. PMID 21536647 DOI: 10.1128/Mcb.01349-10  0.397
2009 Morgan MA, Magnusdottir E, Kuo TC, Tunyaplin C, Harper J, Arnold SJ, Calame K, Robertson EJ, Bikoff EK. Blimp-1/Prdm1 alternative promoter usage during mouse development and plasma cell differentiation. Molecular and Cellular Biology. 29: 5813-27. PMID 19737919 DOI: 10.1128/Mcb.00670-09  0.691
2009 Kuo TC, Schlissel MS. Mechanisms controlling expression of the RAG locus during lymphocyte development. Current Opinion in Immunology. 21: 173-8. PMID 19359154 DOI: 10.1016/J.Coi.2009.03.008  0.529
2007 Ranuncolo SM, Polo JM, Dierov J, Singer M, Kuo T, Greally J, Green R, Carroll M, Melnick A. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nature Immunology. 8: 705-14. PMID 17558410 DOI: 10.1038/Ni1478  0.5
2007 Kuo TC, Shaffer AL, Haddad J, Choi YS, Staudt LM, Calame K. Repression of BCL-6 is required for the formation of human memory B cells in vitro. The Journal of Experimental Medicine. 204: 819-30. PMID 17403935 DOI: 10.1084/Jem.20062104  0.657
2007 Savitsky D, Cimmino L, Kuo T, Martins GA, Calame K. Multiple roles for Blimp-1 in B and T lymphocytes. Advances in Experimental Medicine and Biology. 596: 9-30. PMID 17338172 DOI: 10.1007/0-387-46530-8_2  0.572
2006 Schlissel MS, Kuo TC. AID for innate immunity to retroviral transformation. Immunity. 24: 671-2. PMID 16782023 DOI: 10.1016/J.Immuni.2006.06.005  0.314
2004 Kuo TC, Calame KL. B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. Journal of Immunology (Baltimore, Md. : 1950). 173: 5556-63. PMID 15494505 DOI: 10.4049/Jimmunol.173.9.5556  0.604
2002 Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 17: 51-62. PMID 12150891 DOI: 10.1016/S1074-7613(02)00335-7  0.666
2002 Lin KI, Angelin-Duclos C, Kuo TC, Calame K. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Molecular and Cellular Biology. 22: 4771-80. PMID 12052884 DOI: 10.1128/Mcb.22.13.4771-4780.2002  0.688
Show low-probability matches.